Maverick Simulation Solutions Limited
₹2,475▲16.47%(350.00)
About the company
Maverick Simulation Solutions Limited is an India-based medical technology and simulation company focused on developing advanced training solutions for healthcare and medical education.
The company designs and develops medical simulators that help doctors, nurses, medical students and other healthcare professionals practise clinical and procedural skills in a controlled training environment. These solutions are designed to support hands-on learning without requiring trainees to practise directly on patients.
Maverick Simulation's portfolio includes a range of medical training solutions, such as task trainers, patient simulators, surgical simulators, respiratory simulation systems and virtual anatomy and dissection solutions. The company also provides turnkey simulation solutions for medical colleges, hospitals and other healthcare training institutions.
Fundamentals
Valuation
| Metric | Value |
|---|---|
| 52 week high | ₹2,800 |
| 52 week low | ₹1,995 |
| P/B ratio | 11.2 |
| Debt to equity | 0.24 |
| ROE (%) | 49.32% |
| Book value | ₹207.58 |
| Face value | ₹10 |
52 week high
52 week low
P/B ratio
Debt
Equity
ROE (%)
| Metric | Value |
|---|---|
| 52 week high | ₹2,800 |
| 52 week low | ₹1,995 |
| P/B ratio | 11.2 |
| Debt | 19.4% of capital |
| Equity | 80.6% of capital |
| ROE (%) | 49.32% |
Registry
| Metric | Value |
|---|---|
| PAN number | AARCM2519C |
| ISIN number | INE1BEQ01014 |
Figures in cr ·
Financials
| P&L Statement | 2025Latest | 2024 |
|---|---|---|
| Revenue | 136.3 | 14.2 |
| EBITDA | 61.34 | 1.12 |
| OPM | 45 | 7.89 |
| PBT | 61.3 | 1.26 |
| PAT | 47.8 | 0.94 |
| EPS | 97.35 | 1.98 |
Shareholding Pattern
Promoters
Others
| Holder | Percentage |
|---|---|
| Promoters | 78.74% |
| Others | 21.26% |
Leadership
| Name | Role | Experience | |
|---|---|---|---|
| Anuj Chahal | Founder & CEO | 20+ yrs experience | |
| Dr. Sunil Tomar | Director | 20+ yrs experience | — |
Frequently asked questions
Common questions on Maverick Simulation Solutions Limited—tap a row to read the answer.
Q.1What does Maverick Simulation Solutions Limited do?
Maverick Simulation Solutions Limited develops medical and healthcare simulation solutions used for clinical training and medical education.
Its product portfolio includes:
Task trainers
Patient simulators
Surgical simulators
Respiratory and lung simulators
Virtual anatomy and dissection solutions
Medical simulation laboratories
Turnkey training solutions
These products are designed to help healthcare professionals and students develop practical skills in a simulated environment
Q.2Is Maverick Simulation Solutions Limited listed on the stock exchange?
No. Maverick Simulation Solutions Limited's equity shares are currently unlisted and are not traded on a recognised stock exchange such as NSE or BSE.
Transactions in its shares may take place in the unlisted market, subject to applicable regulations, availability and transaction requirements.
Q.3What are Maverick Simulation Solutions Limited unlisted shares?
Maverick Simulation Solutions Limited unlisted shares represent equity ownership in the company.
Since the company's equity shares are not currently traded on a recognised stock exchange, transactions generally take place through off-market transfers, subject to applicable regulations and transaction procedures.
Q.4Does Maverick Simulation Solutions Limited have an IPO plan?
Investors should not assume that buying Maverick Simulation Solutions Limited unlisted shares guarantees a future IPO or stock-exchange listing.
Any future IPO would depend on the company's strategic decisions, regulatory requirements, market conditions and necessary approvals.
Q.5Does Dhankirti Wealth recommend buying Maverick Simulation Solutions Limited shares?
No. Dhankirti Wealth does not provide buy or sell recommendations for individual unlisted shares.
Dhankirti Wealth facilitates access to information and transactions related to unlisted shares. Investors should independently evaluate the company's fundamentals, valuation, liquidity, risks and suitability for their investment objectives before making any investment decision.
Q.6Where can I enquire about Maverick Simulation Solutions Limited unlisted shares?
You can contact Dhankirti Wealth to enquire about:
Current availability
Indicative pricing
Minimum transaction quantity
Documentation requirements
Demat transfer process
Unlisted Trending shares
High-demand unlisted opportunities currently available for trade.
MARKET INSIGHTS & UPDATES
Read the latest updates, investment ideas, and market insights designed to help investors better understand unlisted and pre-IPO opportunities.

NSE IPO 2026: Dates, Allotment & Listing Details
The much-awaited NSE IPO is set to make a major market debut in September 2026. As per the announced schedule, the IPO will open on 21 September and close on 23 September 2026, followed by share allotment on 24 September and listing on 28 September 2026. With strong investor interest and NSE’s position as one of India’s leading market institutions, the IPO is expected to attract significant attention. Here’s a quick look at the NSE IPO 2026 timeline and important dates investors should know.

Upcoming IPOs in 2026: NSE, Rentomojo, Manipal & Pranav Guide
Four major 2026 IPOs: NSE, Manipal Payment, Rentomojo, Pranav Constructions. For pre-IPO investors, these mark critical transitions from private to public valuations. Conduct due diligence before investing.

Purple Style Labs: From Unlisted Shares to IPO - A Price Journey Worth Noticing
Purple Style Labs is making headlines as it moves from the unlisted market towards its IPO. With its unlisted shares trading around ₹500–₹525 and an IPO price band of ₹546–₹575, the price journey offers an interesting look at how private-market and IPO valuations can differ.

Muthoot FinCorp Unlisted Shares: Q1FY27 Profit Surges to ₹705 Cr | Fundamentals & IPO
Muthoot FinCorp's Q1FY27 profit surged to ₹705.48 crore as the company moves toward a proposed ₹3,000-crore IPO. Here's a look at its financial performance, valuation metrics, asset quality and key fundamentals.

From Debt to Debt-Free: How API Holdings Used Thyrocare to Reshape Its Balance Sheet
API Holdings has repaid ₹1,050 crore of debt by monetising a 9.90% stake in Thyrocare while retaining 51.02% control. Here's how the move reshapes its balance sheet and what it means going forward.

Pre IPO Shares in India: Price, How to Buy & Complete Guide
Learn what Pre IPO Shares are, how their prices are determined, how to buy them in India, and what investors should check before investing in unlisted companies.
